Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS
Canadian Cancer Society (701595)
Boehringer Ingelheim Fonds
Fonds pour la Recherche Médicale dans le Hainaut
Text and Data Mining valid from 2018-04-16
Received: 14 August 2016
Accepted: 12 March 2018
First Online: 16 April 2018
Ethics approval and consent to participate
: The UHN Research Ethics Board approved the study protocol (08–0230-TE) and written informed consent was obtained from each patient. The use of widely available cell lines (ATCC, a publicly accessible repository) does not require ethics approval at our Institution. No permission was required to access the data used for this study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.